Boston Scientific Analyst Price Targets - Benzinga

Boston Scientific Corp

BSXNYSE

Trade with Public

Trade with Public

$47.57

0.621.32%

Last update: Sep 4, 1:08 PM

PRO

Why Is It Moving?™:Boston Scientific shares are trading lower after the FDA disclosed it is aw...

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Boston Scientific Analyst Price Targets

Wall Street analyst price targets and consensus rating for Boston Scientific (BSX).

Price Target Range — 5 Quarters

Analyst Consensus — 22 Analysts

21Buy

1Hold

Consensus RatingBuy# Analysts22Avg. Consensus PT$74Upside to Avg. PT+55.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 25, 2026	TD Cowen	Joshua Jennings	Maintained	Buy	$56
Jul 31, 2026	Argus Research	David Toung	Downgrade	Buy→Hold	—
Jul 30, 2026	UBS	Patrick Wood	PT Cut	Buy	$74→$67
Jul 30, 2026	Citigroup	Joanne Wuensch	PT Cut	Buy	$70→$61
Jul 30, 2026	RBC Capital	Kendall Au	PT Cut	Outperform	$85→$70
Jul 30, 2026	TD Cowen	Joshua Jennings	PT Cut	Buy	$61→$56
Jul 30, 2026	Canaccord Genuity	William Plovanic	PT Cut	Buy	$70→$66
Jul 30, 2026	Truist Securities	Richard Newitter	PT Cut	Buy	$62→$57
Jul 30, 2026	Evercore ISI Group	Vijay Kumar	PT Cut	Outperform	$65→$55
Jul 30, 2026	Wells Fargo	Larry Biegelsen	PT Cut	Equal-Weight	$55→$50
Jul 29, 2026	BTIG	Marie Thibault	PT Cut	Buy	$65→$60
Jul 28, 2026	UBS	Patrick Wood	Assumes	Buy	$95→$74
Jul 27, 2026	Oppenheimer	Suraj Kalia	PT Cut	Outperform	$90→$85
Jul 16, 2026	Truist Securities	Richard Newitter	PT Cut	Buy	$64→$62
Jul 15, 2026	Mizuho	Anthony Petrone	PT Cut	Outperform	$90→$70
Jul 13, 2026	RBC Capital	Shagun Singh	PT Cut	Outperform	$100→$85
Jul 8, 2026	Needham	Mike Matson	PT Cut	Buy	$77→$57
Jul 6, 2026	Evercore ISI Group	Vijay Kumar	PT Cut	Outperform	$78→$65
Jun 25, 2026	Stifel	Rick Wise	PT Cut	Buy	$75→$65
Jun 24, 2026	Jefferies	Matthew Taylor	PT Cut	Buy	$100→$67

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
TD Cowen Reiterates Buy on Boston Scientific, Maintains $56 Price Target

TD Cowen analyst Joshua Jennings reiterates Boston Scientific (NYSE:BSX) with a Buy and maintains $56 price target.

Benzinga Newsdesk

PRO
Argus Research Downgrades Boston Scientific to Hold

Argus Research analyst David Toung downgrades Boston Scientific (NYSE:BSX) from Buy to Hold.

Benzinga Newsdesk

PRO
UBS Maintains Buy on Boston Scientific, Lowers Price Target to $67

UBS analyst Patrick Wood maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $74 to $67.

Benzinga Newsdesk

PRO
Citigroup Maintains Buy on Boston Scientific, Lowers Price Target to $61

Citigroup analyst Joanne Wuensch maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $70 to $61.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Boston Scientific, Lowers Price Target to $70

RBC Capital analyst Kendall Au maintains Boston Scientific (NYSE:BSX) with a Outperform and lowers the price target from $85 to $70.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on Boston Scientific, Lowers Price Target to $56

TD Cowen analyst Joshua Jennings maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $61 to $56.

Benzinga Newsdesk